Opinions: HIV Prevention; PEPFAR; H1N1 Vaccine Donation; Developing Country R&D; Climate Change

HIV Prevention Strategies Are Essential “For nearly 30 years scientists have been trying to break the back of the AIDS epidemic,” but the recent microbicide gel study and an AIDS vaccine trial in Thailand “show just how difficult and how distant that goal is,” according to a Washington Post editorial. “While scientists continue searching for a vaccine or a cure, prevention remains paramount,” the Washington Post concludes (12/16). Can’t Afford To Go ‘Backward’ With PEPFAR PEPFAR “is arguably [former President George W.] Bush’s best legacy…

Go to Source

People who read this also read

• New HIV Model Suggests Killer T Cell For Vaccine
  Limited success in modelling the behaviour of the complex, unusual and unpredictable HIV virus has slowed efforts to develop an effective vaccine to prevent AIDS. A new improved modelling system, developed by Chinese researchers, which attempts to incorporate more of the virus' random behavioural dy...
• Also In Global Health News: Medical Technology Network In N. Korea; MDR-TB Drug Maker Closes; Global Fund Financing; Zuma’s HIV Test; HIV Vaccine; UNI
  N. Korea Launches Medical Video Conference Network North Korea on Tuesday formally launched a medical video conference network "aimed at giving smaller, rural hospitals access to specialists in the capital Pyongyang," the Associated Press reports. "WHO has been providing cameras, computers and ...
• WHO Advises Continued Use Of GSK’s Rotavirus Vaccine In Developing Countries
  The WHO on Monday advised developing countries to continue administering GlaxoSmithKline's Rotarix vaccine - which offers protection to children against the diarrhea-causing rotavirus - after the FDA advised doctors in the U.S. to temporarily stop using the vaccine following the discovery that it wa...
• WHO H1N1 Vaccine Shipments Headed To More Developing Countries
  The WHO on Friday announced "it had delivered the first doses of H1N1 [swine flu] vaccine to Cuba, and a dozen countries in Africa would receive millions of doses in coming weeks," Reuters reports. According to WHO spokeswoman Karen Mah, Cuba received an estimated 1.1 million doses Wednesday, and Ho...
• New Path To Therapeutic HIV Vaccine Discovered By Studying Immunologic Profile Of Rare HIV Controllers
  Based on encouraging results from pre-clinical research, Bionor Immuno AS today announced intentions to take the therapeutic and potentially preventative HIV-vaccine candidate Vacc-C5 into a Phase I/II clinical trial. The research results indicate that Vacc-C5 may induce a protective antibody respon...